REFERENCES
1. Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC.
Complications after cardiac implantable electronic device implantations:
An analysis of a complete, nationwide cohort in Denmark. Eur Heart
J . 2014;35(18):1186-1194. doi:10.1093/eurheartj/eht511
2. Botto GL, Forleo GB, Capucci A, et al. The Italian subcutaneous
implantable cardioverter-defibrillator survey: S-ICD, why not?Europace . 2017;19(11):1826-1832. doi:10.1093/europace/euw337
3. Blomström-Lundqvist C, Traykov V, Erba PA, et al. EHRA international
consensus document on how to prevent, diagnose, and treat cardiac
implantable electronic device infections-endorsed by the HRS, the APHRS,
the LAHRS, ISCVID, and the ESCMID in collaboration with the EACTS.Eur Heart J . 2020;41(21):2012-2032. doi:10.1093/eurheartj/ehaa010
4. Rordorf R, Casula M, Pezza L, et al. Subcutaneous versus transvenous
implantable defibrillator: An updated meta-analysis. Heart
Rhythm . 2021;18(3):382-391. doi:10.1016/j.hrthm.2020.11.013
5. Ricciardi D, Ziacchi M, Gasperetti A, et al. Clinical impact of
defibrillation testing in a real-world S-ICD population: Data from the
ELISIR registry. J Cardiovasc Electrophysiol . 2021;32(2):468-476.
doi:10.1111/jce.14833
6. Wilkoff BL, Fauchier L, Stiles MK, et al. 2015 HRS/EHRA/APHRS/SOLAECE
expert consensus statement on optimal implantable
cardioverter-defibrillator programming and testing. Heart Rhythm .
2016;13(2):e50-e86. doi:10.1016/j.hrthm.2015.11.018
7. Knops RE, Olde Nordkamp LRA, De Groot JR, Wilde AAM. Two-incision
technique for implantation of the subcutaneous implantable
cardioverter-defibrillator. Hear Rhythm . 2013;10(8):1240-1243.
doi:10.1016/j.hrthm.2013.05.016
8. Knops RE, Olde Nordkamp LRA, Delnoy P-PHM, et al. Subcutaneous or
Transvenous Defibrillator Therapy. N Engl J Med .
2020;383(6):526-536. doi:10.1056/nejmoa1915932
9. Kay G, Eby EL, Brown B, et al. Cost-effectiveness of TYRX absorbable
antibacterial envelope for prevention of cardiovascular implantable
electronic device infection. J Med Econ . 2018;21(3):294-300.
doi:10.1080/13696998.2017.1409227
10. Wilkoff BL, Boriani G, Mittal S, et al. Cost-effectiveness of an
antibacterial envelope for cardiac implantable electronic device
infection prevention in the US healthcare system from the WRAP-IT Trial.Circ Arrhythmia Electrophysiol . 2020;13:1073-1082.
doi:10.1161/CIRCEP.120.008503
11. Mitacchione G, Schiavone M, Gasperetti A, Viecca M, Curnis A, Forleo
GB. Neglected lead tip erosion: An unusual case of S-ICD inappropriate
shock. J Cardiovasc Electrophysiol . 2020;31(12):3322-3325.
doi:10.1111/jce.14746